Global Parkinson’s Disease Treatment Market Size study, By Drug Class (Levodopa/carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-inhibitors, Anticholinergics, Other Drugs), By Distribution Channel (Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies), By Patient Care Setting (Hospitals, Clinics), and Regional Forecasts 2022-2028
- BIZ4950387
- 200 Pages
- March 2022
- Pharmaceuticals
Parkinson’s disease is a disorder of the central nervous system that damage the nerve cell in the brain, which causes dopamine levels to drop, and affects movement, often including tremors, rigidity, bradykinesia, and postural volatility as its common symptoms. The rising prevalence of Parkinson’s disease, the growing geriatric population, coupled with the increasing government funding for research and development activities are the primary factors that may surge the market demand across the globe. For instance, according to the Parkinson’s Foundation, in the United States, in 2020, approximately one million people are suffering from Parkinson's disease (PD) that is more than the total number of populations which is diagnosed with multiple sclerosis, muscular dystrophy, and Lou Gehrig's disease (or Amyotrophic Lateral Sclerosis), and the amount is projected to reach 1.2 million individuals by the end of 2030. However, the availability of alternative treatments impedes the growth of the market over the forecast period of 2022-2028. Also, patent expiry of branded drugs and a strong drug pipeline are anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the global Parkinson’s Disease Treatment market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the presence of well-developed healthcare infrastructure, and increasing prevalence of the disorder. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the rising number of research and development activities, as well as supportive government policies would create lucrative growth prospects for the Parkinson’s Disease Treatment market across the Asia-Pacific region.
Major market players included in this report are:
GlaxoSmithKline plc.
Teva Pharmaceutical Industries Ltd.
Boehringer Ingelheim International GmbH.
Impax Laboratories LLC
AbbVie Inc.
Bausch Health.
Lundbeck
Sun Pharmaceutical Industries Ltd.
ACADIA Pharmaceuticals Inc.
Merck & Co. Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class
Levodopa/carbidopa
Dopamine Receptor Agonists
MAO-Inhibitors
COMT-inhibitors
Anticholinergics
Other Drugs
By Distribution Channel
Hospital Pharmacies
Retailer Pharmacies
Online Pharmacies
By Patient Care Setting
Hospitals
Clinics
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Parkinson’s Disease Treatment Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Parkinson’s Disease Treatment Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Parkinson’s Disease Treatment Market, by Drug Class, 2020-2028 (USD Billion)
1.2.3. Global Parkinson’s Disease Treatment Market, by Distribution Channel, 2020-2028 (USD Billion)
1.2.4. Global Parkinson’s Disease Treatment Market, by Patient Care Setting, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Parkinson’s Disease Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Parkinson’s Disease Treatment Market Dynamics
3.1. Parkinson’s Disease Treatment Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growth in ageing population and the increase in the prevalence of Parkinson’s disease
3.1.1.2. Increasing government funding for research and development
3.1.2. Market Challenges
3.1.2.1. Availability of alternative treatments
3.1.3. Market Opportunities
3.1.3.1. Patent expiry of branded drugs
3.1.3.2. Strong drug pipeline
Chapter 4. Global Parkinson’s Disease Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Parkinson’s Disease Treatment Market, by Drug Class
6.1. Market Snapshot
6.2. Global Parkinson’s Disease Treatment Market by Drug Class, Performance - Potential Analysis
6.3. Global Parkinson’s Disease Treatment Market Estimates & Forecasts by Drug Class 2019-2028 (USD Billion)
6.4. Parkinson’s Disease Treatment Market, Sub Segment Analysis
6.4.1. Levodopa/carbidopa
6.4.2. Dopamine Receptor Agonists
6.4.3. MAO-Inhibitors
6.4.4. COMT-inhibitors
6.4.5. Anticholinergics
6.4.6. Other Drugs
Chapter 7. Global Parkinson’s Disease Treatment Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Parkinson’s Disease Treatment Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Parkinson’s Disease Treatment Market Estimates & Forecasts by Distribution Channel 2019-2028 (USD Billion)
7.4. Parkinson’s Disease Treatment Market, Sub Segment Analysis
7.4.1. Hospital Pharmacies
7.4.2. Retailer Pharmacies
7.4.3. Online Pharmacies
Chapter 8. Global Parkinson’s Disease Treatment Market, by Patient Care Setting
8.1. Market Snapshot
8.2. Global Parkinson’s Disease Treatment Market by Patient Care Setting, Performance - Potential Analysis
8.3. Global Parkinson’s Disease Treatment Market Estimates & Forecasts by Patient Care Setting 2019-2028 (USD Billion)
8.4. Parkinson’s Disease Treatment Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Clinics
Chapter 9. Global Parkinson’s Disease Treatment Market, Regional Analysis
9.1. Parkinson’s Disease Treatment Market, Regional Market Snapshot
9.2. North America Parkinson’s Disease Treatment Market
9.2.1. U.S. Parkinson’s Disease Treatment Market
9.2.1.1. Drug Class estimates & forecasts, 2019-2028
9.2.1.2. Distribution Channel estimates & forecasts, 2019-2028
9.2.1.3. Patient Care Setting estimates & forecasts, 2019-2028
9.2.2. Canada Parkinson’s Disease Treatment Market
9.3. Europe Parkinson’s Disease Treatment Market Snapshot
9.3.1. U.K. Parkinson’s Disease Treatment Market
9.3.2. Germany Parkinson’s Disease Treatment Market
9.3.3. France Parkinson’s Disease Treatment Market
9.3.4. Spain Parkinson’s Disease Treatment Market
9.3.5. Italy Parkinson’s Disease Treatment Market
9.3.6. Rest of Europe Parkinson’s Disease Treatment Market
9.4. Asia-Pacific Parkinson’s Disease Treatment Market Snapshot
9.4.1. China Parkinson’s Disease Treatment Market
9.4.2. India Parkinson’s Disease Treatment Market
9.4.3. Japan Parkinson’s Disease Treatment Market
9.4.4. Australia Parkinson’s Disease Treatment Market
9.4.5. South Korea Parkinson’s Disease Treatment Market
9.4.6. Rest of Asia Pacific Parkinson’s Disease Treatment Market
9.5. Latin America Parkinson’s Disease Treatment Market Snapshot
9.5.1. Brazil Parkinson’s Disease Treatment Market
9.5.2. Mexico Parkinson’s Disease Treatment Market
9.6. Rest of The World Parkinson’s Disease Treatment Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. GlaxoSmithKline plc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Teva Pharmaceutical Industries Ltd.
10.2.3. Boehringer Ingelheim International GmbH.
10.2.4. Impax Laboratories LLC
10.2.5. AbbVie Inc.
10.2.6. Bausch Health.
10.2.7. Lundbeck
10.2.8. Sun Pharmaceutical Industries Ltd.
10.2.9. ACADIA Pharmaceuticals Inc.
10.2.10. Merck & Co. Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
TABLE 1. Global Parkinson’s Disease Treatment Market, report scope
TABLE 2. Global Parkinson’s Disease Treatment Market estimates & forecasts by Region 2019-2028 (USD Billion)
TABLE 3. Global Parkinson’s Disease Treatment Market estimates & forecasts by Drug Class 2019-2028 (USD Billion)
TABLE 4. Global Parkinson’s Disease Treatment Market estimates & forecasts by Distribution Channel 2019-2028 (USD Billion)
TABLE 5. Global Parkinson’s Disease Treatment Market estimates & forecasts by Patient Care Setting 2019-2028 (USD Billion)
TABLE 6. Global Parkinson’s Disease Treatment Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 7. Global Parkinson’s Disease Treatment Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 8. Global Parkinson’s Disease Treatment Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global Parkinson’s Disease Treatment Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global Parkinson’s Disease Treatment Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global Parkinson’s Disease Treatment Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global Parkinson’s Disease Treatment Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global Parkinson’s Disease Treatment Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global Parkinson’s Disease Treatment Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. Global Parkinson’s Disease Treatment Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. U.S. Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 17. U.S. Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 18. U.S. Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 19. Canada Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 20. Canada Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 21. Canada Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 22. UK Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 23. UK Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 24. UK Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 25. Germany Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 26. Germany Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 27. Germany Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 28. RoE Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 29. RoE Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 30. RoE Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 31. China Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 32. China Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 33. China Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 34. India Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 35. India Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 36. India Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 37. Japan Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 38. Japan Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 39. Japan Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 40. RoAPAC Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 41. RoAPAC Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 42. RoAPAC Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 43. Brazil Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 44. Brazil Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 45. Brazil Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 46. Mexico Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 47. Mexico Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 48. Mexico Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 49. RoLA Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 50. RoLA Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 51. RoLA Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 52. Row Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 53. Row Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 54. Row Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Parkinson’s Disease Treatment Market
TABLE 56. List of primary sources, used in the study of global Parkinson’s Disease Treatment Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
